These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38566136)

  • 1. Clinical significance of RNA methylation in hepatocellular carcinoma.
    Bao Q; Zeng Y; Lou Q; Feng X; Jiang S; Lu J; Ruan B
    Cell Commun Signal; 2024 Apr; 22(1):204. PubMed ID: 38566136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications.
    Shi Q; Chu Q; Zeng Y; Yuan X; Wang J; Zhang Y; Xue C; Li L
    Cell Commun Signal; 2023 Dec; 21(1):359. PubMed ID: 38111040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
    Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
    Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation-mediated silencing of Neuronatin promotes hepatocellular carcinoma proliferation through the PI3K-Akt signaling pathway.
    Deng Y; Lu L; Liang X; Li J; Zhu D; Huang H; Zhang Y; Zhang X; Chen Y; Liu X; Fu Y
    Life Sci; 2023 Jan; 312():121266. PubMed ID: 36473542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating transcriptomes and somatic mutations to identify RNA methylation regulators as a prognostic marker in hepatocellular carcinoma.
    Yan Y; Luo YH; Zheng DF; Mu T; Wu ZJ
    Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):34-45. PubMed ID: 32563589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights into the Epigenetics of Hepatocellular Carcinoma.
    Wahid B; Ali A; Rafique S; Idrees M
    Biomed Res Int; 2017; 2017():1609575. PubMed ID: 28401148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
    Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
    Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes and pathways, including the CXCL2 axis, altered by DNA methylation in hepatocellular carcinoma.
    Subat S; Mogushi K; Yasen M; Kohda T; Ishikawa Y; Tanaka H
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):675-684. PubMed ID: 30564899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in hepatocellular carcinoma.
    Nagaraju GP; Dariya B; Kasa P; Peela S; El-Rayes BF
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):622-632. PubMed ID: 34324953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of RNA modifications in hepatocellular carcinoma: functional mechanism and potential applications.
    Liu JX; Zhang X; Xu WH; Hao XD
    Front Immunol; 2024; 15():1439485. PubMed ID: 39229278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.
    Qiu X; Huang Y; Zhou Y; Zheng F
    Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
    Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
    Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
    Fang Q; Chen H
    Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of DNA methylation in hepatocellular carcinoma.
    Sceusi EL; Loose DS; Wray CJ
    HPB (Oxford); 2011 Jun; 13(6):369-76. PubMed ID: 21609368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated mH2A1 serves as an unfavorable prognostic indicator and promotes the progress of hepatocellular carcinoma (HCC).
    Yang G; Yao Y; Wu D; Guo H; Zhou S; Sun D; Guo X; Zheng T; Wang J; Zhang S; Wang Y; Song R; Ke S; Liu Y; Meng F; Liang Y; Lu Z; Liu L
    Life Sci; 2020 Dec; 263():118576. PubMed ID: 33058912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
    Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
    Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.